FDA inspection
Akron Pharma, Inc.: FDA inspection ending Aug 12, 2025
FDA inspection 1279897 · No Action Indicated (NAI) · Fairfield, NJ
Key facts
| Inspection ID | 1279897 |
|---|---|
| Firm | Akron Pharma, Inc. |
| FEI number | 3013943804 |
| Address | 373 Us Highway 46 Ste 117 |
| City | Fairfield |
| State | NJ |
| ZIP | 07004 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Aug 12, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Foodborne Biological Hazards |
| Product type | Food/Cosmetics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data